Bo-Jeong Pyun

981 total citations
8 papers, 844 citations indexed

About

Bo-Jeong Pyun is a scholar working on Molecular Biology, Toxicology and Complementary and alternative medicine. According to data from OpenAlex, Bo-Jeong Pyun has authored 8 papers receiving a total of 844 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Toxicology and 2 papers in Complementary and alternative medicine. Recurrent topics in Bo-Jeong Pyun's work include Angiogenesis and VEGF in Cancer (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Natural product bioactivities and synthesis (2 papers). Bo-Jeong Pyun is often cited by papers focused on Angiogenesis and VEGF in Cancer (3 papers), Bioactive Compounds and Antitumor Agents (2 papers) and Natural product bioactivities and synthesis (2 papers). Bo-Jeong Pyun collaborates with scholars based in South Korea, Ethiopia and United States. Bo-Jeong Pyun's co-authors include Young‐Guen Kwon, Tae‐Yoon Kim, Jeong‐Ki Min, Young Mi Kim, Seung‐Taek Lee, Sewook Hwang, Yong Song Gho, Yong‐Sun Maeng, Hyun-Jung Choi and Young‐Myeong Kim and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Cancer Research.

In The Last Decade

Bo-Jeong Pyun

8 papers receiving 830 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo-Jeong Pyun South Korea 8 465 232 168 152 105 8 844
Eva Besemfelder Germany 12 461 1.0× 141 0.6× 144 0.9× 146 1.0× 186 1.8× 12 870
Yi‐Chin Fong Taiwan 22 546 1.2× 161 0.7× 251 1.5× 91 0.6× 266 2.5× 35 1.1k
Alexandra Mazharian United Kingdom 21 433 0.9× 282 1.2× 67 0.4× 96 0.6× 135 1.3× 33 1.3k
Alexander Schütz Germany 16 505 1.1× 208 0.9× 174 1.0× 221 1.5× 496 4.7× 25 1.1k
Houjie Liang China 19 459 1.0× 115 0.5× 215 1.3× 107 0.7× 238 2.3× 36 862
Gemma Basatemur France 5 461 1.0× 362 1.6× 203 1.2× 122 0.8× 46 0.4× 6 911
James Surapisitchat United States 11 581 1.2× 204 0.9× 73 0.4× 155 1.0× 66 0.6× 13 946
Hera Chaudhury United Kingdom 9 500 1.1× 275 1.2× 173 1.0× 126 0.8× 67 0.6× 9 836
Huanbai Xu China 17 558 1.2× 184 0.8× 240 1.4× 113 0.7× 175 1.7× 33 1.0k

Countries citing papers authored by Bo-Jeong Pyun

Since Specialization
Citations

This map shows the geographic impact of Bo-Jeong Pyun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo-Jeong Pyun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo-Jeong Pyun more than expected).

Fields of papers citing papers by Bo-Jeong Pyun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo-Jeong Pyun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo-Jeong Pyun. The network helps show where Bo-Jeong Pyun may publish in the future.

Co-authorship network of co-authors of Bo-Jeong Pyun

This figure shows the co-authorship network connecting the top 25 collaborators of Bo-Jeong Pyun. A scholar is included among the top collaborators of Bo-Jeong Pyun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo-Jeong Pyun. Bo-Jeong Pyun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Pyun, Bo-Jeong, Sung Woo Kim, Ji Young Yoo, et al.. (2015). TTAC-0001, a human monoclonal antibody targeting VEGFR-2/KDR, blocks tumor angiogenesis. mAbs. 7(5). 957–968. 19 indexed citations
2.
Pyun, Bo-Jeong, Haeng Ran Seo, Yeung Bae Jin, et al.. (2013). Inhibition of Snail1-DNA-PKcs Protein-Protein Interface Sensitizes Cancer Cells and Inhibits Tumor Metastasis. Journal of Biological Chemistry. 288(45). 32506–32516. 10 indexed citations
3.
Jin, Yeung Bae, Bo-Jeong Pyun, Hee Kyung Jin, et al.. (2012). Effects of simultaneous combined exposure to CDMA and WCDMA electromagnetic field on immune functions in rats. International Journal of Radiation Biology. 88(11). 814–821. 12 indexed citations
4.
Seo, Haeng Ran, Woo Duck Seo, Bo-Jeong Pyun, et al.. (2011). Radiosensitization by celastrol is mediated by modification of antioxidant thiol molecules. Chemico-Biological Interactions. 193(1). 34–42. 30 indexed citations
5.
Choi, Hyun-Jung, Jeong‐Ki Min, Bo-Jeong Pyun, et al.. (2009). Interleukin-33 induces angiogenesis and vascular permeability through ST2/TRAF6-mediated endothelial nitric oxide production. Blood. 114(14). 3117–3126. 251 indexed citations
6.
Pyun, Bo-Jeong, Sun Choi, Yoonji Lee, et al.. (2008). Capsiate, a Nonpungent Capsaicin-Like Compound, Inhibits Angiogenesis and Vascular Permeability via a Direct Inhibition of Src Kinase Activity. Cancer Research. 68(1). 227–235. 76 indexed citations
7.
Min, Jeong‐Ki, Jung Ho Kim, Young-Lai Cho, et al.. (2006). 20(S)-Ginsenoside Rg3 prevents endothelial cell apoptosis via inhibition of a mitochondrial caspase pathway. Biochemical and Biophysical Research Communications. 349(3). 987–994. 94 indexed citations
8.
Kim, Young Mi, Sewook Hwang, Bo-Jeong Pyun, et al.. (2002). Endostatin Blocks Vascular Endothelial Growth Factor-mediated Signaling via Direct Interaction with KDR/Flk-1. Journal of Biological Chemistry. 277(31). 27872–27879. 352 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026